Scott Gottlieb, MD, is bullish on the opportunities artificial intelligence could bring to EHRs, decision support and more.At AcademyHealths 2018 Health Datapalooza on Thursday, the U.S. Food and Drug Administration offered a vote of confidence for artificial intelligence in healthcare, promising more refined strategies for regulation, touting its tech incubator for AI innovation and announcing a new machine learning partnership with Harvard.”Were implementing a new approach to the review of artificial intelligence,” said FDA Commissioner Scott Gottlieb, MD. As one example, he pointed to the agency’s approval earlier this year of a new clinical decision support software that uses AI algorithms to help alert neurovascular specialists of brain deterioration faster than existing technologies.”AI holds enormous promise for the future of medicine, and were actively developing a new regulatory framework to promote innovation in this space and support the use of AI-based technologies,” said Gottlieb. “So, as we apply our Pre-Cert program where we focus on a firms underlying quality well account for one of the greatest benefits of machine learning that it can continue to learn and improve as it is used.”

Source: Click here

Share this article

Facebook Comments